
Pramod Singh
Trialogix – MICRO Fall 2025
Published April 15, 2026
As part of our ‘Meet Our Founders’ series today, we introduce Pramod Singh, Co-Founder of Trialogix based in Cary, NC. Trialogix uses AI to design faster, more precise clinical trials by predicting feasibility, cost, and risk, and auto-generating protocol documents, timelines, and budgets.
Q: What problem are you trying to solve and what influenced you to start your company?
A: Clinical trials are incredibly slow, expensive, and risky, and most of those problems trace back to trial design decisions made when teams have the least clarity. After speaking with people across biotech, pharma, and CROs, we kept hearing the same frustration: trial design is still a manual, fragmented process with no real way to predict feasibility, cost, or patient impact before a study launches. Those gaps lead to avoidable delays, protocol amendments, and failed studies that waste years and billions of dollars. We started Trialogix because it was clear the industry needed a smarter, more data-driven way to design trials that sites want to run and patients want to join.
Q: When did you know you wanted to take an entrepreneurial path?
A: I knew entrepreneurship was my path in 2017 when, as head of data science at Yodlee, I kept watching brilliant ideas die inside committee meetings while tiny startups outside were moving 10× faster and actually shipping products that customers loved. The exact moment came during a late-night hackathon in our Bangalore office: my small skunkworks team built a working alternative-data model in 4 weeks that the official roadmap had scheduled for 18 months; seeing it instantly beat every bank’s internal score made me realize I no longer wanted to ask for permission to build the future. After that, every big-company role felt like wearing borrowed clothes; Teaching AI Product Management at Duke and now building Inquisite and Trialogix with my co-founders only confirmed what I felt that night in 2017: creating something from nothing and putting it directly into people’s hands is the only work that has ever felt like home.
Q: What have you enjoyed most about starting your own company?
A: What I’ve enjoyed most is the pure ownership of turning a blank sheet of paper into something that real customers pay for and love. I love the speed: the fact that an idea we sketch on a Tuesday can be coded, tested, and live in production by Friday, with zero layers of approval. I also cherish building a tiny, high-trust teams where everyone knows exactly why their work matters. Above all, it’s the privilege of working every day with co-founder Jon, whom I genuinely admire, knowing we are collectively betting our time and reputation on a vision we all believe in—that feeling of shared mission and mutual respect is irreplaceable.
Q: What is one thing you wish you understood about entrepreneurship before you ever got started?
A: I wish I had truly understood how much entrepreneurship is an emotional marathon rather than a financial sprint—cash flow stress, customer rejections, and the constant self-doubt can hit harder than any business problem. I also did not realize that almost every “overnight success” story I admired had actually taken 3–6 years of quiet grinding, which would have saved me from the unrealistic timelines I set for my startups in the early days. The third surprise was discovering that the real job of a founder is not to have all the answers, but to relentlessly recruit, inspire, and retain people who are smarter than you in every domain. Finally, I wish someone had told me that saying “no” to good opportunities (and even to good investors) is often the only way to protect the one great thing you’re trying to build.
While visiting Cary, Pramod recommends:
- Visit the 3 college campuses, Duke, UNC Chapel Hill, and NCSU. Go to the North Carolina Museum of Art and the North Carolina Museum of Natural Sciences in downtown Raleigh. Get ice cream from Two Roosters, pizza from Ponysaurus, pastries from Paul and Jack bakery, and drinks at ZincHouse Winery & Brewery.
Support Trialogix and Pramod by:
- You can support us by connecting us with biotech, pharma, and CRO leaders involved in trial design, as well as with investors focused on AI in life sciences. Early pilot partners and data access are the biggest accelerators for us right now.